Skip to main navigation Skip to search Skip to main content

Immunogenic compositions comprising Sbi protein and uses thereof

Research output: Patent

Abstract

Novel vaccine adjuvant technology based on Staphylococcus aureus immunomodulator Sbi
Original languageEnglish
Patent numberWO2018096089A1
IPC A61K39/04, A61K39/09,A61K39/385,A61K39/39
Priority date25/11/16
Filing date24/11/17
Publication statusPublished - 31 May 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Immunogenic compositions comprising Sbi protein and uses thereof'. Together they form a unique fingerprint.

Cite this